MediWound vs FORE Biotherapeutics

MediWound vs FORE Biotherapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: MediWound is on 47/100 and FORE Biotherapeutics on 56/100.

MediWound logo
MediWoundGlobal leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.
Try MediWound
FORE Biotherapeutics logo
FORE BiotherapeuticsPrecision oncology company developing cancer therapies guided by proprietary functional genomics.
Try FORE Biotherapeutics

Where each one leads

MediWound

  • agent readiness: 45/100 against 37/100
  • domain rating: 42/100 against 35/100
  • headcount: 105 against 56

FORE Biotherapeutics

  • our overall score: 56/100 against 47/100
  • funding raised: $232M against $25.0M

At a glance

MeasureMediWoundFORE Biotherapeutics
What it isGlobal leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.Precision oncology company developing cancer therapies guided by proprietary functional genomics.
CategoryHealthcare, MedTech, HealthTech, BiotechnologyHealthcare, Drug Development, Genomics, Next Generation Sequencing
Sells toBusiness modelB2BB2B
OfferingSoftwareSoftware
Founded20002011
HeadquartersYavne, IsraelPhiladelphia, United States
StatusActiveActive

Size, funding and growth

MeasureMediWoundFORE Biotherapeutics
Employees10556
Headcount growthLast 12 monthsNot published+8.2%
Total funding$25.0M$232M
Latest roundPost-IPOSeries D-2 Extension
ValuationNot published$75.0M
LinkedIn followersNot published4,584

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureMediWoundFORE Biotherapeutics
StartupHub scoreOur 0-100 rating47/10056/100
Traction59/10058/100
TeamNot published70/100
Search visibility4/10038/100
Quality58/10055/100
Agent readinessHow well an AI agent can read and act on the siteD (45/100)F (37/100)
Domain ratingLink authority, 0-10042/10035/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureMediWoundFORE Biotherapeutics
CDNCloudflareNot detected
CMSWordPressWordPress
FrameworksJqueryJquery

MediWound vs FORE Biotherapeutics: common questions

Which is better, MediWound or FORE Biotherapeutics?

On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do MediWound and FORE Biotherapeutics compare on the numbers?

MediWound leads on agent readiness (45/100 against 37/100), domain rating (42/100 against 35/100), headcount (105 against 56). FORE Biotherapeutics leads on our overall score (56/100 against 47/100), funding raised ($232M against $25.0M).

Read the full MediWound review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other MediWound alternatives we track.